Influence of promoter region variants of insulin-like growth factor pathway genes on the strength-training response of muscle phenotypes in older adults

Journal of Applied Physiology

Volumn 103, Issue 5, 2007, Pages 1678-1687

  Hand, Brian D ^a,b   Kostek, Matthew C ^a   Ferrell, Robert E ^c   Delmonico, Matthew J ^a,c   Douglass, Larry W ^d   Roth, Stephen M ^a   Hagberg, James M ^a   Hurley, Ben F ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b TOWSON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

Genetics; Muscle quality; Muscle strength; Muscle volume

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CALCINEURIN B GENE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DNA POLYMORPHISM; ELDERLY CARE; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN EXPERIMENT; KNEE FUNCTION; MALE; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE TRAINING; MUTATOR GENE; NORMAL HUMAN; NUCLEOTIDE REPEAT; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; DINUCLEOTIDE REPEATS; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE, SKELETAL; PHENOTYPE; PHOSPHOPROTEIN PHOSPHATASES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEX FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35648992951     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00420.2007     Document Type: Article

References (55)

1. Baxter RC, Martin JL, Beniac VA. High molecular weight insulin-like growth factor binding protein complex. J Biol Chem 264: 11843-11848, 1989.
2. Clarkson PM, Devaney JM, Gordish-Dressman H, Thompson PD, Hubal MJ, Urso M, Price TB, Angelopoulos TJ, Gordon PM, Moyna NM, Pescatello LS, Visich PS, Zoeller RF, Seip RL, Hoffman EP. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol 99: 154-163, 2005.
3. Deal C, Ma J, Wilkin F, Paquette J, Rozen F, Ge B, Hudson T, Stampfer M, Pollak M. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab 86: 1274-1280, 2001.
4. DeLellis K, Ingles S, Kolonel L, McKean-Cowdin R, Henderson B, Stanczyk F, Probst-Hensch NM. IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer 88: 277-282, 2003.
5. Delmonico MJ, Kostek MC, Doldo NA, Hand BD, Bailey JA, Rabon-Stith KM, Carignan C, Hurley BF. Effects of moderate velocity strength training on peak muscle power and movement velocity: do women respond differently from men? J Appl Physiol 99: 1712-1718, 2005.
6. Dunn SE, Burns JL, Michel RN. Calcineurin is required for skeletal muscle hypertrophy. J Biol Chem 274: 21908-21912, 1999.
7. Dunn SE, Chin ER, Michel RN. Matching of calcineurin activity to upstream effectors is critical for skeletal muscle growth. J Cell Biol 151: 663-672, 2000.
8. Fiatarone Singh MA, Ding M, Manfredi TJ, Solares GS, O'Neill EF, Clements KM, Ryan ND, Kehayias JJ, Fielding RA, Evans WJ. Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders. Am J Physiol Endocrinol Metab 277: E135-E143, 1999.
9. Florini JR, Ewton DZ, Coolican SA. Growth hormone and insulin-like growth factor system in myogenesis. Endocr Rev 17: 481-517, 1996.
10. Folland J, Leach B, Little T, Hawker K, Myerson S, Montgomery H, Jones D. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol 85: 575-579, 2000.
11. Foulstone EJ, Savage PB, Crown AL, Holly JM, Stewart CE. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts. J Cell Physiol 195: 70-79, 2003.
12. Hameed M, Lange KH, Andersen JL, Schjerling P, Kjaer M, Harridge SD. The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol 555: 231-240, 2004.
13. Hameed M, Orrell RW, Cobbold M, Goldspink G, Harridge SD. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol 547: 247-254, 2003.
14. Hendrix LJ, Carter MW, Scott DT. Covariance analyses with heterogeneity of slopes in fixed models. Biometrics 38: 641-650, 1982.
15. Hill M, Goldspink G. Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J Physiol 549: 409-418, 2003.
16. Hill M, Wernig A, Goldspink G. Muscle satellite (stem) cell activation during local tissue injury and repair. J Anat 203: 89-99, 2003.
17. Hurley BF, Redmond RA, Pratley RE, Treuth MS, Rogers MA, Goldberg AP. Effects of strength training on muscle hypertrophy and muscle cell disruption in older men. Int J Sports Med 16: 378-384, 1995.
18. Hurley BF, Roth SM. Strength training in the elderly: effects on risk factors for age-related diseases. Sports Med 30: 249-268, 2000.
19. Huygens W, Thomis MA, Peeters MW, Vlietinck RF, Beunen GP. Determinants and upper-limit heritabilities of skeletal muscle mass and strength. Can J Appl Physiol 29: 186-200, 2004.
20. Ivey FM, Roth SM, Ferrell RE, Tracy BL, Lemmer JT, Hurlbut DE, Martel GF, Siegel EL, Fozard JL, Metter EJ, Fleg JL, Hurley BF. The effects of age, gender, and myostatin genotype on the hypertrophic response to strength training and detraining. J Gerontol A Biol Sci Med Sci 55: M641-M648, 2000.
21. Jernstrom H, Chu W, Vesprini D, Tao Y, Majeed N, Deal C, Pollak M, Narod SA. Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol Genet Metab 72: 144-154, 2001.
22. Jernstrom H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10: 377-384, 2001.
23. Kato I, Eastham J, Li B, Smith M, Yu H. Genotype-phenotype analysis for the polymorphic CA repeat in the insulin-like growth factor-I (IGF-I) gene. Genet Epidemiol 18: 203-209, 2003.
24. Kostek MC, Delmonico MJ, Reichel JB, Roth SM, Douglass L, Ferrell RE, Hurley BF. Muscle strength response to strength training is influenced by insulin-like growth factor 1 (IGF-1) genotype in older adults. J Appl Physiol 98: 2147-2154, 2005.
25. Larsson L, Grimby G, Karlsson J. Muscle strength and speed of movement in relation to age and muscle morphology. J Appl Physiol 46: 451-456, 1979.
26. Lemmer JT, Hurlbut DE, Martel GF, Tracy BL, Ivey FM, Metter EJ. Age and gender responses to strength training and detraining. Med Sci Sports Exerc 32: 1505-1512, 2000.
27. Lindle RS, Metter EJ, Lynch NA, Fleg JL, Fozard JL, Tobin J, Roy TA, Hurley BF. Age and gender comparisons of muscle strength in 654 women and men aged 20-93 yr. J Appl Physiol 83: 1581-1587, 1997.
28. Lynch NA, Metter EJ, Lindle RS, Fozard JL, Tobin JD, Roy TA, Fleg JL, Hurley BF. Muscle quality I. Age-associated differences between arm and leg muscle groups. J Appl Physiol 86: 188-194, 1999.
29. Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 57: B359-B365, 2002.
30. Metter EJ, Talbot LA, Schrager M, Conwit R. Arm-cranking muscle power and arm isometric muscle strength are independent predictors of all-cause mortality in men. J Appl Physiol 96: 814-821, 2004.
31. Miller MD, Crotty M, Giles LC, Bannerman E, Whitehead C, Cobiac L, Daniels LA, Andrews G. Corrected arm muscle area: an independent predictor of long-term mortality in community-dwelling older adults? J Am Geriatr Soc 50: 1272-1277, 2002.
32. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 85: 115-122, 1998.
33. Miyazaki M, Hitomi Y, Kizaki T, Ohno H, Haga S, Takemasa T. Contribution of the calcineurin signaling pathway to overload-induced skeletal muscle fiber-type transition. J Physiol Pharmacol 55: 751-764, 2004.
34. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998.
35. Musaro A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N. IGF-1 induces skeletal muscle myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400: 581-585, 1999.
36. Olson EN, Williams RS. Remodeling muscles with calcineurin. Bioassays 22: 510-519, 2000.
37. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 99: 9213-9218, 2002.
38. Parsons SA, Millay DP, Wilkins BJ, Bueno OF, Tsika GL, Neilsen JR, Liberatore CM, Yutzey KE, Crabtree GR, Tsika RW, Molkentin JD. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem 279: 26192-26200, 2004.
39. Riechman SE, Balasekaran G, Roth SM, Ferrell RE. Association of interleukin-15 and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol 97: 2214-2219, 2004.
40. Ritter O, Hack S, Schuh K, Rothlein N, Perrot A, Osterziel KJ, Schulte HD, Neyses L. Calcineurin in human heart hypertrophy. Circulation 105: 2265-2269, 2002.
41. Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, Witte S, Rogers J, Bilezikian JP. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-1 gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 83: 2286-2290, 1998.
42. Roth SM, Ferrell RE, Hurley BF. Strength training for the prevention and treatment of sarcopenia. J Nutr Health Aging 4: 143-155, 2000.
43. Schuller AG, Groffen C, van Neck JW, Zwarthoff EC, Drop SL. cDNA cloning and mRNA expression of the six mouse insulin-like growth factor binding proteins. Mol Cell Endocrinol 104: 57-66, 1994.
44. Semsarian C, Wu MJ, Ju YK, Marciniec T, Yeoh T, Aleen DG, Harvey RP, Graham RM. Skeletal muscle hypertrophy is mediated by a Ca2+ -dependent calcineurin signaling pathway. Nature 400: 576-581, 1999.
45. Serrano AL, Murgia M, Pallafacchina G, Calabria E, Coniglio P, Lomo T, Schiaffino S. Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibers but not muscle growth. Proc Natl Acad Sci USA 98: 13108-13113, 2001.
46. Slattery ML, Baumgartner KB, Byers T, Guiliano A, Sweeney C, Herrick J, Curtin K, Murtaugh M, Wolff R. Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women. Cancer Causes Control 16: 1147-1157, 2005.
47. Spangenburg EE, Abraha T, Childs TE, Pattison JS, Booth FW. Skeletal muscle IGF-binding protein-3 and -5 expressions are age, muscle, and load dependent. Am J Physiol Endocrinol Metab 284: E340-E350, 2003.
48. Stewart CE, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76: 1005-1026, 1996.
49. Talmadge RJ, Otis JS, Rittler MR, Garcia ND, Spencer SR, Lees SJ, Naya FJ. Calcineurin activation influences muscle phenotype in a muscle-specific fashion. BMC Cell Biol 5: 1-12, 2004.
50. Tang W, Arnett DK, Devereux RB, Panagiotou D, Province MA, Miller MB, de Simone G, Gu C, Ferrell RE. Identification of a novel 5-base pair deletion in calcineurin B (PPP3R1) promoter region and its association with left ventricular hypertrophy. Am Heart J 150: 845-851, 2005.
51. Thomis MA, Beunen GP, Maes HH, Blimkie CJ, Leemputte MV, Claessens AL, Marchal G, Willems E, Vlietinek RF. Strength training: importance of genetic factors. Med Sci Sports Exerc 30: 724-731, 1998.
52. Toogood AA, Shalet SM. Ageing and growth hormone status. Bailleres Clin Endocrinol Metab 12: 281-296, 1998.
53. Tracy BL, Ivey FM, Hurlbut D, Martel GF, Lemmer JT, Siegel EL, Metter EJ, Fozard JL, Fleg JL, Hurley BF. Muscle quality. II. Effects of strength training in 65- to 75-yr-old men and women. J Appl Physiol 86: 195-201, 1998.
54. Villafuerte BC, Zhang WN, Phillips LS. Insulin and insulin-like growth factor-I regulate hepatic insulin-like growth factor binding protein-3 by different mechanisms. Mol Endocrinol 10: 622-630, 1996.
55. Wang MG, Yi H, Guerini D, Klee CB, McBride OW. Calcineurin A alpha (PPP3CA), calcineurin A beta (PPP3CB) and calcineurin B (PPP3R1) are located on human chromosomes 4, 10q21→q22 and 2p16→p15, respectively. Cytogenet Cell Genet 72: 236-241, 1996.